Journal Article
Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel
Dana M. Roque; Natalia Buza; Michelle Glasgow; Stefania Bellone; Ileana Bortolomai; Sara Gasparrini; Emiliano Cocco; Elena Ratner; Dan-Arin Silasi; Masoud Azodi; Thomas J. Rutherford; Peter E. Schwartz; Alessandro D. Santin
Clinical & Experimental Metastasis · Vol. 31, Issue 1 · pp. 101-110 · 2014